戻る Agenda
[S42] Think About Informed Consent from a Patient’s Perspective – What Can We Do to Promote Proper Understanding of Clinical Trials and PatientFriendly Clinical Trials?
Session Chair(s)
Kazuo Hasegawa
Representative Director, OnestepLung Cancer Patient Network ONE STEP, Japan
Informed consent is the first important process for patients to learn about and understand clinical trials. Recently, volume and complexity of Informed consent documents are increasing. In this session, we will discuss how we can improve informed consent documents and communication from a patient’s perspective based on the recent efforts in Japan and global.
Speaker(s)
David P. Leventhal, MBA
Enterprise Clinical Trial Data Sharing Lead, Global Data Dissemination, Pfizer Inc, United States
Bringing Patient Centricity to Informed Consent and Promoting Understanding of Clinical Research Participation
Yumiko Miyazaki, MSC
Associate Director, Medical Affairs Diabetes, Eli Lilly Japan K.K., Japan
How Do We Make “Easy-to-Understand ICF” Come True?
Yukari Suzuki, RN
Chief Clinical Research Coordinator, Clinical and Translational Research Center, Nigata University Medical and Dental Hospital, Japan
From the Standpoint of CRC That Uses Various ICFs and Supports Many Subjects
Shinsuke Amano
Director, Group Nexus Japan, Japan